Application

18387577 · Use Of 2-Phenyl-6-(1H-Imidazol-1-YL) Quinazoline For Treating Neurodegenerative Diseases, Preferably Alzheimer's Disease

Filed 2023-11-07 · Abandoned The official file ↗ · Art unit 1628 · Examiner Jared Barsky Hard · CPC A61K 31/517 · ROTTAPHARM BIOTECH S.R.L. · ELMORE PATENT LAW GROUP, PC

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

26.4 mo

to disposition 33.8 mo

Statutes raised

103

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.